Open navigation
Search
Offices – Ukraine
Explore all Offices
Global Reach

Apart from offering expert legal consultancy for local jurisdictions, CMS partners up with you to effectively navigate the complexities of global business and legal environments.

Explore our reach
Insights – Ukraine
Explore all insights
Search
Expertise
Insights

CMS lawyers can provide future-facing advice for your business across a variety of specialisms and industries, worldwide.

Explore topics
Offices
Global Reach

Apart from offering expert legal consultancy for local jurisdictions, CMS partners up with you to effectively navigate the complexities of global business and legal environments.

Explore our reach
CMS Ukraine
Insights
About CMS

Select your region

Past event Event · 29 Sept 2022, 10:00 - 18:30 CET · Ukraine

Global Life Sciences & Healthcare Forum 2022

The EGG, Brussels

Event details

Programme

29 Sep 2022 Past event

10:00 - 18:30 CET

Venue

Brussels, Belgium

Uncertain times, an evolving legal framework: managing risks and ensuring social responsibility in the life sciences & healthcare sector

Join us for our Global Life Sciences & Healthcare Forum!  The Forum being both in person and online.

With the sector looking closer at the impact it is having on the environment and social needs, as well as the role governance plays in how it conducts business, we will explore:

  • Keynote speaker: Amitrajit Saha, Team Leader, Africa HIV, Health & Development Team, United Nations Development Programme
  • Environmental sustainability: pitfalls and opportunities in a tightening regulatory framework
    • ESG as a value creation lever in the Life Sciences sector in Europe
    • Sustainability Claims: legal challenges and best practices
Speakers

  • Jan-Frederik Jerratsch, Managing Director & Partner, Boston Consulting Group
  • Charline Wurzer, Principal, Boston Consulting Group
  • CMS specialists

 

  • Social responsibility and improving access to health: navigating the legal challenges The proposed EU Directive on Supply Chain Due Diligence: what to expect?
  • Bridging the health gap: facilitating access to health with telemedicine, digital tools, virtual reality
Speakers

  • CMS specialists

 

We will also discuss how increasing levels of risk over the last year have impacted the sector, including:

  • Keynote speaker: Martin Gallizia, Multinational Client Director, and head of Chemie/Pharma/Medtech DACH, AON
  • Technology Transformation
    • CMS Report on Technology Transformation: Managing Risks in a Changing Landscape:  New technologies give rise to new risks. Managing these risks should be a priority, but adequate measures still need to be developed. We report on our findings as they relate to the life sciences & healthcare sector.
    • Insuring IP risks: An insurer’s approach to assessing and mitigating IP risks, and the challenges and opportunities in this area.
Speakers

  • Paul Wishart, Managing Director, Sybaris
  • CMS specialists

 

  • A changing commercial landscape
    • Supply chain disruption and contractual hardship / termination: Best practices and considerations in the context of pandemic and war; Shortage of resources and rising inflation: Pricing and competition developments.
Speakers

  • Laetitia Szaller, General Counsel & VP Business Development, AM Pharma
  • Omina Technologies
  • CMS specialists

To register for either in person and online, click the options below. The Forum is free to attend.

Programme

TimeItem
10.00 – 10.05Opening
Nick Beckett, Global Co-Head of CMS Life Sciences & Healthcare Sector Group
10.05 – 10.30

Keynote: ESG
Amitrajit Saha, Team Leader, Africa HIV, Health & Development Team, United Nations Development Programme

10.30 – 11.30Environmental sustainability: pitfalls and opportunities in a tightening regulatory framework 
• ESG as value creation lever in the Life Sciences sector in Europe 
• Sustainability claims: Legal challenges and best practices 
11.30 – 12.00Coffee break
12.00 – 13.00Social responsibility and improving access to health: navigating the legal challenges
• The proposed EU Directive on Supply Chain Due Diligence: what to expect? 
• Bridging the health gap: facilitating access to health with telemedicine, digital tools, virtual reality  
13.00 – 14.30Lunch
14.30 – 15.00Keynote: Managing Risk
Martin Gallizia, Multinational Client Director, and head of Chemie/Pharma/Medtech DACH, AON
15.00 – 16.00Technology transformation
• Technology Transformation: Managing Risks in a Changing Landscape
• Q&A/Fireside chat – Insuring IP risks
16.00 – 16.30Coffee
16.30 – 17.30A changing commercial landscape: current risks and challenges 
17.30 – 17.35Closing
Jens Wagner, Global Co-Head of CMS Life Sciences & Healthcare Sector Group
17.35 – 18.30Drinks

Should you have any questions regarding this Forum, please contact us.


Morning session: ESG

With the sector looking closer at the impact it is having on the environment and social needs, as well as the role governance plays in how it conducts business, we will explore:

  • Keynote speaker: UN representative
  • Environmental sustainability: pitfalls and opportunities in a tightening regulatory framework
    • ESG as a value creation leaver in the Life Sciences sector in Europe
    • Sustainability Claims: legal challenges and best practices
    • The proposed EU Directive on Supply Chain Due Diligence: what to expect?
Speakers

  • Jan-Fredrik Jerratsch, Boston Consulting Group 
  • Charline Wurzer, Boston Consulting Group
  • CMS specialists

 

  • Improving access to health: navigating the legal challenges
    • Bridging the health gap: facilitating access to health with telemedicine, digital tools, virtual reality
    • Access to medicine: alternative models of distribution of medicine
    • Equity in life sciences/clinical studies
Speakers

  • CMS specialists

Afternoon session: Managing risk

We will also discuss how increasing levels of risk over the last year have impacted the sector, including:

  • Keynote speaker: Martin Gallizia, Multinational Client Director, and head of Chemie/Pharma/Medtech DACH, AON
  • Technology Transformation CMS Report on Technology Risks: New technologies give rise to new risks. Managing these risks should be a priority, but adequate measures still need to be developed. We report on our findings as they relate to the life sciences & healthcare sector
    • Insuring IP risks: An insurer’s approach to assessing and mitigating IP risks, and the challenges and opportunities in this area
Speakers

  • Paul Wishart, Sybaris
  • CMS specialists

 

  • A changing commercial landscape
    • Supply chain disruption and contractual hardship / termination: Best practices and considerations in the context of pandemic and war; Shortage of resources and rising inflation: Pricing and competition developments
Speakers

  • Laetitia Szaller, General Counsel & VP Business Development, AM Pharma
  • CMS specialists


Learn more on the topic

Learn more about our ESG services

Technology Transformation: Managing Risks in a Changing Landscape

Additional resources

CMS On the Pulse

CMS Expert Guides - Life Sciences & Healthcare

Global Digital Health Festival - Virtual: Digital trends transforming HealthTech

Global Life Sciences & Healthcare Festival 2021 - Virtual

Location

The EGG
Rue Bara 175
1070 Brussels
Belgium
Go to Google Maps
Open Google Maps © OpenStreetMap

More events

  • Ukraine
    03 Mar 2026

    IP Insights webinar series 2026

  • Ukraine
    19 Mar 2026

    CMS Nordic Health Summit

  • Ukraine
    23 Mar 2026

    CMS at PTMG Spring 2026

  • Ukraine
    21 Apr 2026

    On the Pulse webinar series 2026 - Spring

Local market knowledge. Global outlook

We provide future-facing legal advice to help your organisation thrive. Combining local market knowledge and a global perspective, and with lawyers in locations worldwide, your organisation benefits from the expertise it needs, even across borders.

About CMS
People across CMS Find a Lawyer
7,200+ Lawyers
1,300+ Partners
Locations across CMS Find an office
50+ Countries
90+ Offices
21 Member firms
Back to top